IP Verse

Methods, Cells & Organisms - EP3418379

The patent EP3418379 was granted to Kymab on Dec 9, 2020. The application was originally filed on Sep 18, 2014 under application number EP18174860A. The patent is currently recorded with a legal status of "Revoked".

EP3418379

KYMAB
Application Number
EP18174860A
Filing Date
Sep 18, 2014
Status
Revoked
Jul 21, 2023
Grant Date
Dec 9, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSDec 9, 2020STEINECKEADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONWO2013041846
EXAMINATIONWO2013061078
EXAMINATIONWO2013176772
OTHEREP1456346
OTHEREP1572862

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- Daniel J Dickinson ET AL, "Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination", Nature Methods, New York, (20130901), vol. 10, no. 10, doi:10.1038/nmeth.2641, ISSN 1548-7091, pages 1028 - 1034, XP055340980
EXAMINATION- Daniel J Dickinson ET AL, "Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination", Nature Methods, New York, (20130901), vol. 10, no. 10, doi:10.1038/nmeth.2641, ISSN 1548-7091, pages 1028 - 1034, XP055340984
EXAMINATION- You-Tzung Chen ET AL, "PiggyBac Transposon-Mediated, Reversible Gene Transfer in Human Embryonic Stem Cells", Stem Cells and Development, US, (20100601), vol. 19, no. 6, doi:10.1089/scd.2009.0118, ISSN 1547-3287, pages 763 - 771, XP055248208
EXAMINATION- W. Fujii ET AL, "Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease", Nucleic Acids Research, (20130830), vol. 41, no. 20, doi:10.1093/nar/gkt772, ISSN 0305-1048, pages 1 - 9, XP055270998
EXAMINATION- S. Kondo ET AL, "Highly Improved Gene Targeting by Germline-Specific Cas9 Expression in Drosophila", GENETICS, US, (20130903), vol. 195, no. 3, doi:10.1534/genetics.113.156737, ISSN 0016-6731, pages 715 - 721, XP055248203
OTHER- CYRANOSKI D., "Gene-edited pigs to be sold as pets", Nature, (20150000), vol. 526, page 18, XP055722280-
OTHER- Janet Cotter, Dana Perls, "Genetically Engineered Animals: From Lab to Factory Farm", Friends of the Earth, (20190900), pages 1 - 41, XP055722286-
OTHER- SCADUTO C.M., "Methods for creating transgenic primates", LAB ANIMAL, (20160800), vol. 45, no. 8, pages 291 - 292, XP055722277
SEARCH- ANN RAN F ET AL, "Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity", CELL, CELL PRESS, US, vol. 154, no. 6, doi:10.1016/J.CELL.2013.08.021, ISSN 0092-8674, (20130912), pages 1380 - 1389, (20130829), XP002718603 [A] 1-14 * the whole document *
SEARCH- GAJ THOMAS ET AL, "ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (20130509), vol. 31, no. 7, doi:10.1016/J.TIBTECH.2013.04.004, ISSN 0167-7799, pages 397 - 405, XP028571313 [AD] 1-14 * the whole document *
SEARCH- WOONG Y HWANG ET AL, "Efficient genome editing in zebrafish using a CRISPR-Cas system", NATURE BIOTECHNOLOGY, (20130129), vol. 31, no. 3, doi:10.1038/nbt.2501, ISSN 1087-0156, pages 227 - 229, XP055086625 [X] 12,13 * the whole document * [I] 14
SEARCH- WOONG Y HWANG ET AL, "Efficient genome editing using RNA-guided Nucleases", HHS PUBLIC ACCESS AUTHOR MANUSCRIPT, (20130301), doi:10.1038/nbt.2501, pages 1 - 12, XP055401624 [X] 12,13 * the whole document *
SEARCH- PATRICK D HSU ET AL, "DNA targeting specificity of RNA-guided Cas9 nucleases", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, UNITED STATES, vol. 31, no. 9, doi:10.1038/NBT.2647, ISSN 1546-1696, (20130901), pages 827 - 832, (20130721), XP002718604 [A] 1-14 * the whole document *
SEARCH[ ] - PATRICK D HSU ET AL, "Supplementary Information: DNA targeting specificity of RNA-guided Cas9 nuclease, Supplementary Methods", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, UNITED STATES, vol. 31, no. 9, doi:10.1038/NBT.2647, ISSN 1546-1696, (20130901), pages 1 - 26, (20130721), XP002718605 [ ] * the whole document *
SEARCH[ ] - CONG L ET AL, "Supplementary Material to : Multiplex Genome Engineering Using CRISPR/Cas Systems", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, (20130103), vol. 339, no. 6121, doi:10.1126/SCIENCE.1231143, ISSN 0036-8075, pages 819 - 823, XP002730884 [ ] * the whole document *
SEARCH- L. CONG ET AL, "Multiplex Genome Engineering Using CRISPR/Cas Systems", SCIENCE, (20130215), vol. 339, no. 6121, doi:10.1126/science.1231143, ISSN 0036-8075, pages 819 - 823, XP055067741 [AD] 1-14 * the whole document *
SEARCH- HAGEN RICHTER ET AL, "Exploiting CRISPR/Cas: Interference Mechanisms and Applications", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, (20130712), vol. 14, no. 7, doi:10.3390/ijms140714518, pages 14518 - 14531, XP055153313 [A] 1-14 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents